Logo image of RCS

PIMCO STRATEGIC INCOME FUND (RCS) Stock Price, Quote, News and Overview

NYSE:RCS - New York Stock Exchange, Inc. - US72200X1046 - Currency: USD

6.58  +0.16 (+2.49%)

Fundamental Rating

2

Taking everything into account, RCS scores 2 out of 10 in our fundamental rating. RCS was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of RCS have multiple concerns. RCS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RCS had positive earnings in the past year.
In the past year RCS had a positive cash flow from operations.
In multiple years RCS reported negative net income over the last 5 years.
Of the past 5 years RCS 4 years had a positive operating cash flow.
RCS Yearly Net Income VS EBIT VS OCF VS FCFRCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 3.27%
ROE 14.43%
ROIC 4.69%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCS Yearly ROA, ROE, ROICRCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

RCS's Profit Margin has improved in the last couple of years.
RCS's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of RCS has declined.
Industry RankSector Rank
OM 69.18%
PM (TTM) 103.57%
GM 67.5%
OM growth 3Y-10.13%
OM growth 5Y-2.84%
PM growth 3Y-14.52%
PM growth 5Y9.24%
GM growth 3Y-10.14%
GM growth 5Y-2.85%
RCS Yearly Profit, Operating, Gross MarginsRCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

1

2. Health

2.1 Basic Checks

RCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RCS Yearly Shares OutstandingRCS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
RCS Yearly Total Debt VS Total AssetsRCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.42, we must say that RCS is in the distress zone and has some risk of bankruptcy.
RCS has a debt to FCF ratio of 2.65. This is a good value and a sign of high solvency as RCS would need 2.65 years to pay back of all of its debts.
RCS has a Debt/Equity ratio of 0.60. This is a neutral value indicating RCS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 2.65
Altman-Z -0.42
ROIC/WACCN/A
WACCN/A
RCS Yearly LT Debt VS Equity VS FCFRCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

RCS has a Current Ratio of 0.39. This is a bad value and indicates that RCS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.39 indicates that RCS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
RCS Yearly Current Assets VS Current LiabilitesRCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

More info and screens

1

3. Growth

3.1 Past

RCS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.08%.
RCS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.59% yearly.
RCS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.78%.
RCS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.48% yearly.
EPS 1Y (TTM)5.08%
EPS 3Y-18.36%
EPS 5Y1.59%
EPS Q2Q%-11.11%
Revenue 1Y (TTM)6.78%
Revenue growth 3Y-2.68%
Revenue growth 5Y-5.48%
Sales Q2Q%8.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCS Yearly Revenue VS EstimatesRCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.61 indicates a reasonable valuation of RCS.
The average S&P500 Price/Earnings ratio is at 26.25. RCS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.61
Fwd PE N/A
RCS Price Earnings VS Forward Price EarningsRCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.79
EV/EBITDA N/A
RCS Per share dataRCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.68
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.68%, RCS is a good candidate for dividend investing.
RCS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 8.68%

5.2 History

RCS has paid a dividend for at least 10 years, which is a reliable track record.
RCS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
RCS Yearly Dividends per shareRCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

86.21% of the earnings are spent on dividend by RCS. This is not a sustainable payout ratio.
DP86.21%
EPS Next 2YN/A
EPS Next 3YN/A
RCS Yearly Income VS Free CF VS DividendRCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
RCS Dividend Payout.RCS Dividend Payout, showing the Payout Ratio.RCS Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO STRATEGIC INCOME FUND

NYSE:RCS (6/2/2025, 4:10:02 PM)

6.58

+0.16 (+2.49%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.62%
Inst Owner Change3.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap306.96M
Analysts0
Price TargetN/A
Short Float %1.08%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield 8.68%
Yearly Dividend0.54
Dividend Growth(5Y)N/A
DP86.21%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-12 2025-05-12 (0.04)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.61
Fwd PE N/A
P/S 10.96
P/FCF 6.79
P/OCF 6.79
P/B 1.53
P/tB 1.53
EV/EBITDA N/A
EPS(TTM)0.62
EY9.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.97
FCFY14.73%
OCF(TTM)0.97
OCFY14.73%
SpS0.6
BVpS4.31
TBVpS4.31
PEG (NY)N/A
PEG (5Y)6.68
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 14.43%
ROCE 9.38%
ROIC 4.69%
ROICexc 4.69%
ROICexgc 4.82%
OM 69.18%
PM (TTM) 103.57%
GM 67.5%
FCFM 161.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-10.13%
OM growth 5Y-2.84%
PM growth 3Y-14.52%
PM growth 5Y9.24%
GM growth 3Y-10.14%
GM growth 5Y-2.85%
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 2.65
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.43
Cash Conversion N/A
Profit Quality 155.97%
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -0.42
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.08%
EPS 3Y-18.36%
EPS 5Y1.59%
EPS Q2Q%-11.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.78%
Revenue growth 3Y-2.68%
Revenue growth 5Y-5.48%
Sales Q2Q%8.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.16%
EBIT growth 3Y-12.55%
EBIT growth 5Y-8.16%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.32%
OCF growth 3YN/A
OCF growth 5YN/A